date,title,source
Oct-22-18,ESMO 2018: Athenex Presented Encouraging Clinical Trial Efficacy and Safety Results of Oraxol in the Treatment of Metastatic Breast Cancer,GlobeNewswire
Oct-26-18,"Recent Analysis Shows Prologis, Delek Logistics Partners, Fabrinet, New York Mortgage Trust, Petroleo Brasileiro S.A.- Petrobras, and Athenex Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Oct-29-18,Athenex Announces FDA Allowance of Investigational New Drug Application of Eribulin ORA to Begin Clinical Trials,GlobeNewswire
Nov-01-18,"Athenex, Inc. to Report Third Quarter Earnings Results on November 14, 2018",GlobeNewswire
Nov-14-18,"Athenex Inc (ATNX) CEO and Chairman of the Board Johnson Yiu Nam Lau Bought $418,800 of Shares",GuruFocus.com
Nov-14-18,Edited Transcript of ATNX earnings conference call or presentation 14-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-14-18,Athenex: 3Q Earnings Snapshot,Associated Press
Nov-14-18,"Athenex, Inc. Announces Third Quarter 2018 Financial Results and Provides Corporate Update",GlobeNewswire
Nov-19-18,"Athenex Inc (ATNX) CEO and Chairman of the Board Johnson Yiu Nam Lau Bought $117,500 of Shares",GuruFocus.com
Nov-26-18,Athenex Announces Initiation of a Phase I/II Clinical Study of Oraxol in Combination with Anti-PD1,GlobeNewswire
Nov-29-18,Athenex Announces Licensing Agreement with PharmaEssentia for Rights to Oradoxel (Oral Docetaxel) in Certain Asian Territories,GlobeNewswire
Dec-06-18,"Recent Analysis Shows Athenex, National CineMedia, Macy's, Manulife Financial, CBS, and Strategic Education Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Dec-06-18,Athenex to Host an R&D Day on December 17 in New York,GlobeNewswire
Dec-11-18,CORRECTION: Athenex Announces Positive Second Cohort Results of Oraxol-plus-Ramucirumab Phase 1b Clinical Trial in Gastric Cancer,GlobeNewswire
Dec-11-18,Athenex Announces Positive Second Cohort Results of Oraxol-plus-Ramucirumab Phase 1b Clinical Trial in Gastric Cancer,GlobeNewswire
